SCHEMBL3070641

SCHEMBL3070641

C[P+](C)(C)C.O=P([O-])(OC1CCCCC1)OC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.48
NPSR1 Q6W5P4 3/20 0.44
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.36
TERT O14746 1/20 0.35
UCHL3 P15374 1/20 0.35
AKT1 P31749 1/20 0.35
MAPK14 Q16539 1/20 0.35
GPR84 Q9NQS5 3/20 0.33
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
MMP2 P08253 3/20 0.32
CA12 O43570 2/20 0.32
CA9 Q16790 2/20 0.32
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31474639 0.89 ACHE (0.48) ACHENPSR1MEN1KMT2AGAA
SCHEMBL11608393 0.89 ACHE (0.48) ACHENPSR1MEN1KMT2AGAA
SCHEMBL11705645 0.89 ACHE (0.48) ACHENPSR1MEN1KMT2AGAA
SCHEMBL11603446 0.86 ACHE (0.45) ACHENPSR1MEN1KMT2AGAA
SCHEMBL11702587 0.86 ACHE (0.45) ACHENPSR1MEN1KMT2AGAA
SCHEMBL3072638 0.84 ACHE (0.43) ACHENPSR1MEN1KMT2AGAA
SCHEMBL11607577 0.81 ACHE (0.40) ACHENPSR1MEN1KMT2ATERT
SCHEMBL11706413 0.81 ACHE (0.40) ACHENPSR1MEN1KMT2ATERT
SCHEMBL3059510 0.81 ACHE (0.41) ACHENPSR1MEN1KMT2AGAA
SCHEMBL3056539 0.79 AKT1 (0.43) ACHENPSR1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2540761-B1 CURABLE RESIN COMPOSITION MITSUBISHI GAS CHEMICAL CO (JP) 2016-08-31 EP disclosed
US-8853346-B2 Curable resin composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-10-07 US disclosed
US-20130018168-A1 CURABLE RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-01-17 US disclosed
EP-2540761-A1 CURABLE RESIN COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2013-01-02 EP disclosed
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2010-10-21 US disclosed
US-20090118442-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT ELL, RAD54L, RPP30 ACHE 3796/4885NPSR1 4649/4885MEN1 4816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.